Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromelain and curcumin for rheumatoid arthritis
IRCT20120415009472N29Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules, Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of bromelain and curcumin in rheumatoid arthritis (RA), sponsored by Iran University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
bromelaincurcumin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on IRCT20120415009472N29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120415009472N29.